Clear Harbor Asset Management’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
Other funds holding ABUS
Clear Harbor Asset Management's ABUS Position: Q3 2026 in Review
Clear Harbor Asset Management sold out of Arbutus Biopharma (ABUS) in Q3 2026, closing a stake of 27,000 shares — an estimated $130K sold.
Clear Harbor Asset Management first reported a position in ABUS in Q4 2022 and held it in 15 quarters. The position peaked at $360K in Q4 2025. 216 funds tracked by Wall St. Rank hold ABUS as of Q3 2026.
- Clear Harbor Asset Management reported no remaining Arbutus Biopharma position as of Q3 2026 after selling out during the quarter.
- Clear Harbor Asset Management sold 27,000 Arbutus Biopharma shares in Q3 2026, an estimated $130K.
- Clear Harbor Asset Management first reported a position in Arbutus Biopharma in Q4 2022 and held it in 15 quarters.
- Clear Harbor Asset Management's Arbutus Biopharma position peaked at $360K in Q4 2025.
- 216 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q3 2026.
Based on Clear Harbor Asset Management's 13F filing for Q3 2026, filed 5 Nov 2026.